Quality of life and medication therapy adherence in primary health care: focus on common mental disorders
##plugins.themes.bootstrap3.article.main##
Abstract
Introduction. Medication therapy adherence is a challenge in the clinical practice of health providers.
Objective. To identify predictors of nonadherence to medication therapy and quality of life (QoL) in medication users.
Method. A cross-sectional analytical study was conducted at five primary health care (PHC) units in Brazil. Standardized tools included the Self-Reporting Questionnaire, Measurement of Treatment Adherence, and World Health Organization Quality-of-Life-Bref, in addition to a sociodemographic and treatment-related questionnaire.
Results. Participants with common mental disorders (CMDs) who used psychotropic medication were more likely to be nonadherent to medication treatment. Sociodemographic variables, presence of a CMD, and psychotropic medication use were key predictors of lower QoL in patients treated at PHC.
Discussion and conclusion. The findings of this study could inform interventions designed to improve medication therapy adherence and train public health care professionals to enhance health care.
References
Ausín, B., Zamorano, A., & Muñoz, M. (2020). Relationship between quality of life and sociodemographic, physical and mental health variables in people over 65 in the community of Madrid. International Journal of Environmental Research and Public Health, 17(22), 1-11. https://doi.org/10.3390/ijerph17228528
Barros, F. C., Matijasevich, A., Santos, I. S., Horta, B. L., da Silva, B. G. C., Munhoz, T. N., Fazel, S., Stein, A., Pearson, R. M., Anselmi, L., & Rohde, L. A. (2018). Social inequalities in mental disorders and substance misuse in young adults: A birth cohort study in Southern Brazil. Social Psychiatry and Psychiatric Epidemiology, 53(7), 717-726. https://doi.org/10.1007/s00127-018-1526-x
Bielderman, A., de Greef, M. H. G., Krijnen, W. P., & van der Schans, C. P. (2015). Relationship between socioeconomic status and quality of life in older adults: a path analysis. Quality of Life Research, 24(7), 1697-1705. https://doi.org/10.1007/s11136-014-0898-y
Brody, D. J., & Gu, Q. (2020). Antidepressant Use Among Adults: United States, 2015-2018. NCHS Data Brief, 377, 1-8.
Caron, J., Cargo, M., Daniel, M., & Liu, A. (2019). Predictors of Quality of Life in Montreal, Canada: A Longitudinal Study. Community Mental Health Journal, 55(2), 189-201. https://doi.org/10.1007/s10597-018-0340-y
Delgado, A. B., & Lima, M. L. (2001). Contributo para a validação concorrente de uma medida de adesão aos tratamentos. Psicologia, Saúde & Doenças, 2(2), 81-100. Retrieved from https://www.researchgate.net/publication/237033567_Contributo_para_a_avalicao_concorrente_de_uma_medida_de_adesao_aos_tratamentos
El Abdellati, K., De Picker, L., & Morrens, M. (2020). Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis. Frontiers in Neuroscience, 14, 531763. https://doi.org/10.3389/fnins.2020.531763
Estrela, M., Herdeiro, M. T., Ferreira, P. L., & Roque, F. (2020). The use of antidepressants, anxiolytics, sedatives and hypnotics in Europe: Focusing on mental health care in portugal and prescribing in older patients. International Journal of Environmental Research and Public Health, 17(22), 1-12. https://doi.org/10.3390/ijerph17228612
Ferretti, F., Castanha, A. C., Padoan, E. R., Lutinski, J., & Silva, M. R. da. (2018). Quality of life in the elderly with and without chronic pain. Brazilian Journal of Pain, 1(2), 111-115. https://doi.org/10.5935/2595-0118.20180022
Fleck, M. P. A., Louzada, S., Xavier, M., Chachamovich, E., Vieira, G., Santos, L., & Pinzon, V. (2000). ApplicationofthePortugueseversion of the abbreviated instrumentof quality life WHOQOL-bref. Revista de Saude Publica, 34(2), 178-183. https://doi.org/10.1590/s0034-89102000000200012
Gast, A., & Mathes, T. (2019). Medication adherence influencing factors - An (updated) overview of systematic reviews. Systematic Reviews, 8(1), 1-17. https://doi.org/10.1186/s13643-019-1014-8
González-Blanch, C., Hernández-de-Hita, F., Muñoz-Navarro, R., Ruíz-Rodríguez, P., Medrano, L. A., & Cano-Vindel, A. (2018). The association between different domains of quality of life and symptoms in primary care patients with emotional disorders. Scientific Reports, 8(1), 1-10. https://doi.org/10.1038/s41598-018-28995-6
Gupta, P., Patel, P., Štrauch, B., Lai, F. Y., Akbarov, A., Marešová, V., White, C. M., Petrák, O., Gulsin, G. S., Patel, V., Rosa, J., Cole, R., Zelinka, T., Holaj, R., Kinnell, A., Smith, P. R., Thompson, J. R., Squire, I., Widimský, J., ... Tomaszewski, M. (2017). Risk Factors for Nonadherence to Antihypertensive Treatment. Hypertension, 69(6), 1113-1120. https://doi.org/10.1161/HYPERTENSIONAHA.116.08729
Ismail, L. M. N., Selim, M. A.-A., & Elkhashab, S. O. Y. (2017). Factors affecting medication adherence among patients with rheumatic disorders. Journal of Nursing Education and Practice, 7(8), 7. https://doi.org/10.5430/jnep.v7n8p7
Jin, H., Kim, Y., & Rhie, S. J. (2016). Factors affecting medication adherence in elderly people. Patient Preference and Adherence, 10, 2117-2125. https://doi.org/10.2147/PPA.S118121
Kim, J., Combs, K., Downs, J., & Tillman III, F. (2018). Medication Adherence: The Elephant in the Room. US Pharmacist, 43(1), 30-34. Retrieved from https://www.uspharmacist.com/article/medication-adherence-the-elephant-in-the-room
Kopp, M., Fleischhacker, W. W., Stürz, K., Ruedl, G., Kumnig, M., & Rumpold, G. (2011). Poor health behaviour and reduced quality of life of people treated with psychotropic drugs. Human Psychopharmacology: Clinical and Experimental, 26(2), 161-167. https://doi.org/10.1002/hup.1190
Kroenke, K., Outcalt, S., Krebs, E., Bair, M. J., Wu, J., Chumbler, N., & Yu, Z. (2013). Association between anxiety, health-related quality of life and functional impairment in primary care patients with chronic pain. General Hospital Psychiatry, 35(4), 359-365. https://doi.org/10.1016/j.genhosppsych.2013.03.020
Lam, W. Y., & Fresco, P. (2015). Medication Adherence Measures: An Overview. BioMed Research International, 2015, 217047. https://doi.org/10.1155/2015/217047
Lee, K. H., Xu, H., & Wu, B. (2020). Genderdifferences in quality of life among community-dwelling older adults in low- and middle-income countries: results from the Study on globalAGEing and adult health (SAGE). BMC PublicHealth, 20(1), 114. https://doi.org/10.1186/s12889-020-8212-0
Magin, P., Tapley, A., Dunlop, A. J., Davey, A., van Driel, M., Holliday, E., Morgan, S., Henderson, K., Ball, J., Catzikiris, N., Mulquiney, K., Spike, N., Kerr, R., & Holliday, S. (2018). Changes in Australian Early-Career General Practitioners’ Benzodiazepine Prescribing: A Longitudinal Analysis. Journal of General Internal Medicine, 33(10), 1676-1684. https://doi.org/10.1007/s11606-018-4577-5
Malhotra, S., & Shah, R. (2015). Women and mental health in India: An overview. Indian Journal of Psychiatry, 57(Supp), 205-211. https://doi.org/10.4103/0019-5545.161479
Mari, J. D. J., & Williams, P. (1986). A Validity Study of a Psychiatric Screening Questionnaire (SRQ-20) in primary care in the city of Sao Paulo. British Journal of Psychiatry, 148, 23-26. https://doi.org/10.1192/bjp.148.1.23
Martin, L. R., Feig, C., Maksoudian, C. R., Wysong, K., & Faasse, K. (2018). A perspective on nonadherence to drug therapy: Psychological barriers and strategies to overcome nonadherence. Patient Preference and Adherence, 12, 1527-1535. https://doi.org/10.2147/PPA.S155971
Miasso, A. I., Telles Filho, P. C. P., Borges, T. L., Pereira Junior, A. C., Vedana, K. G. G., Shasanmi, R. O., & Gimenes, F. R. E. (2017). Quality of Life in Brazil’s Family Health Strategy: Common Mental Disorders, Use of Psychotropic Drugs and Sociodemographic Factors. Archives of Psychiatric Nursing, 31(1), 68-72. https://doi.org/10.1016/j.apnu.2016.08.005
Miasso, A. I., Telles Filho, P. C. P., Borges, T. L., Pereira Júnior, A. C., Vedana, K. G. G., Shasanmi, R., & Escobar Gimenes, F. R. (2016). Adherence to Psychotropic Medications and Associated Factors in Primary Health Care. Issues in Mental Health Nursing, 37(10), 775-783. https://doi.org/10.1080/01612840.2016.1214854
Ogawa, Y., Takeshima, N., Hayasaka, Y., Tajika, A., Watanabe, N., Streiner, D., & Furukawa, T. A.. (2019). Antidepressants Plus Benzodiazepines for Adults with Major Depression. The Cochrane Database of Systematic Reviews, 101(9), 527-528. https://doi.org/10.1002/14651858.CD001026.pub2
Pereira Júnior, A. do C., Miasso, A. I., Telles Filho, P. C. P., Castilho, E. C. D., & Vedana, K. G. G. (2021). Evaluation of Quality of Life of Primary Health Care Patients in Brazil: Influence of Drug Interactions, Common Mental Disorders, and Use of Psychiatric Medication. Community Mental Health Journal, 58(2), 240-248. https://doi.org/10.1007/s10597-021-00815-8
Pino-Sedeño, T. Del, Peñate, W., Cuevas, C. D. Las, Valcarcel-Nazco, C., Fumero, A., Serrano-Pérez, P. G., Acosta-Artiles, F. J., Ramos-García, V., León-Salas, B., Bejarano-Quisoboni, D., & Trujillo-Martín, M. M. (2019). Effectiveness and cost-effectiveness of a multicomponent intervention to improve medication adherence in people with depressive disorders - mapdep: A study protocol for a cluster randomized controlled trial. Patient Preference and Adherence, 13, 309-319. https://doi.org/10.2147/PPA.S172963
Prakash, J., Yadav, Y., Srivastava, K., & Madhusudan, T. (2019). Psychosocial correlates of medication adherence in patients with depressive illness. Industrial Psychiatry Journal, 28(1), 135. https://doi.org/10.4103/ipj.ipj_78_19
Semahegn, A., Torpey, K., Manu, A., Assefa, N., Tesfaye, G., & Ankomah, A. (2018). Psychotropic medication non-adherence and associated factors among adult patients with major psychiatric disorders: A protocol for a systematic review. Systematic Reviews, 7(1), 1-5. https://doi.org/10.1186/s13643-018-0676-y
Semahegn, A., Torpey, K., Manu, A., Assefa, N., Tesfaye, G., & Ankomah, A. (2020). Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: A systematic review and meta-analysis. Systematic Reviews, 9(1), 1-18. https://doi.org/10.1186/s13643-020-1274-3
Soósová, M. S. (2016). Determinants of quality of life in the elderly. Central European Journal of Nursing and Midwifery, 7(3), 484-493. https://doi.org/10.15452/CEJNM.2016.07.0019
Tanguay Bernard, M. M., Luc, M., Carrier, J. D., Fournier, L., Duhoux, A., Côté, E., Lessard, O., Gibeault, C., Bocti, C., & Roberge, P. (2018). Patterns of benzodiazepines use in primary care adults with anxiety disorders. Heliyon, 4(7), e00688. https://doi.org/10.1016/j.heliyon.2018.e00688
Tavakoli-Fard, N., Mortazavi, S. A., Kuhpayehzadeh, J., & Nojomi, M. (2016). Quality of life, Work ability and other important indicators of women’s occupational health. International Journal of Occupational Medicine and Environmental Health, 29(1), 77-84. https://doi.org/10.13075/ijomeh.1896.00329
The WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551-558. https://doi.org/10.1017/s0033291798006667
Wand, T. (2019). Is it time to end our complicity with pharmacocentricity? International Journal of Mental Health Nursing, 28(1), 3-6. https://doi.org/10.1111/inm.12554
World Health Organization [WHO]. (2021). Primary health care. https://www.who.int/news-room/fact-sheets/detail/primary-health-care
Zheng, F., Duan, Y., Li, J., Lai, L., Zhong, Z., Hu, M., & Ding, S. (2019). Somatic symptoms and their association with anxiety and depression in Chinese patients with cardiac neurosis. Journal of International Medical Research, 47(10), 4920-4928. https://doi.org/10.1177/0300060519869711
